跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIPRAX 110 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIPRAX 110 MG CAPSULAS DURAS EFG
Approved
STANDARD
DABIPRAX 110 MG CAPSULAS DURAS EFG
Ptr Pharma Consulting, Lda.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 24, 2024
Approval ID
9b438ce1043255bb
Company
Ptr Pharma Consulting, Lda.
Type
Standard
Approval Details
Approval Id
9b438ce1043255bb
Drug Cima Aemps Name
DABIPRAX 110 MG CAPSULAS DURAS EFG
Register Number
89657
Holder Company Name
Ptr Pharma Consulting, Lda.
Marketing Company Name
Ptr Pharma Consulting, Lda.
Authorization Date
2024-06-24
Dosage Form
CÁPSULA DURA
Dose
110 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Ptr Pharma Consulting, Lda.
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
126,83 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 24, 2024
Approval ID
9b438ce1043255bb
Type
Standard
Back to CIMA-AEMPS Approvals